TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 73 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $18,515,000 | +10.3% | 390,294 | -14.8% | 1.14% | +28.1% |
| Q1 2015 | $16,788,000 | -17.9% | 458,202 | -11.1% | 0.89% | -15.6% |
| Q4 2014 | $20,456,000 | +106.0% | 515,159 | +3.5% | 1.06% | +109.1% |
| Q3 2014 | $9,932,000 | +531.8% | 497,858 | +327.1% | 0.51% | +593.2% |
| Q2 2014 | $1,572,000 | -52.6% | 116,556 | -61.7% | 0.07% | -49.7% |
| Q1 2014 | $3,317,000 | – | 304,682 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |